1-3 of 3
Alina Dulau-Florea
Close
Sort by
Journal Articles

Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trial

Clinical Trials & Observations
Maria A. Lizarralde-Iragorri, Bindu Parachalil Gopalan, Brenda Merriweather, Jennifer Brooks, Mai Hill, Dianna Lovins, Ruth Pierre-Charles, Ann Cullinane, Alina Dulau-Florea, Duck-Yeon Lee, Rafael Villasmil, Neal Jeffries, Arun S. Shet
Journal: Blood Advances
Blood Adv (2023) 8 (1): 172–182.
https://doi.org/10.1182/bloodadvances.2023011542
Published: 2023
Includes: Supplemental data
Journal Articles

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant

Clinical Trials & Observations
Dai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, Constance Yuan, Hao-Wei Wang, Hong Zhou, Mark Raffeld, Liqiang Xi, Seth M. Steinberg, Julie Feurtado, Lacey James-Echenique, Chin-Hsien Tai, Keyur P. Patel, Raul C. Braylan, Katherine R. Calvo, Irina Maric, Alina Dulau-Florea, Robert J. Kreitman
Journal: Blood Advances
Blood Adv (2021) 5 (23): 4807–4816.
https://doi.org/10.1182/bloodadvances.2021005039
Published: 2021
Journal Articles

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

Clinical Trials & Observations
Ifeyinwa Emmanuela Obiorah, Bhavisha A. Patel, Emma M. Groarke, Weixin Wang, Megan Trick, Amanda K. Ombrello, Marcela A. Ferrada, Zhijie Wu, Fernanda Gutierrez-Rodrigues, Jennifer Lotter, Lorena Wilson, Patrycja Hoffmann, Daniela Ospina Cardona, Nisha Patel, Alina Dulau-Florea, Daniel L. Kastner, Peter C. Grayson, David B. Beck, Neal S. Young, Katherine R. Calvo
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3203–3215.
https://doi.org/10.1182/bloodadvances.2021004976
Published: 2021
Includes: Supplemental data